Home/Filings/4/0001213900-24-015028
4//SEC Filing

PHOENIX BIOTECH SPONSOR, LLC 4

Accession 0001213900-24-015028

CIK 0001870404other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 7:38 PM ET

Size

16.4 KB

Accession

0001213900-24-015028

Insider Transaction Report

Form 4
Period: 2024-02-14
Transactions
  • Other

    Series A Convertible Preferred Stock

    2024-02-14$1000.00/sh1,555$1,555,0000 total
    Exercise: $10.00Common Stock (155,500 underlying)
  • Other

    Common Stock

    2024-02-144,171,2461,000,000 total
  • Exercise/Conversion

    Convertible Promissory Note

    2024-02-1400 total
    Exercise: $10.00Common Stock
  • Other

    Common Stock

    2024-02-141,125,0004,171,246 total
  • Exercise/Conversion

    Series A Convertible Preferred Stock

    2024-02-14$1000.00/sh+1,555$1,555,0001,555 total
    Exercise: $10.00Common Stock (155,500 underlying)
  • Other

    Warrants

    2024-02-14349,9980 total
    Exercise: $11.50From: 2024-03-15Exp: 2029-02-14Common Stock (349,998 underlying)
Footnotes (4)
  • [F1]Represents shares of Common Stock, Series A Preferred Stock or warrants, as applicable, distributed-in-kind by the reporting person to its members, pro rata and without consideration.
  • [F2]Upon closing of the Issuer's initial business combination, the aggregate principal amount of the Convertible Promissory Note converted into shares of Series A Convertible Preferred Stock (the "Series A Preferred Stock") at a conversion price equal to $10.00.
  • [F3]Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price, which is currently $10.00, subject to adjustments. The Series A Preferred Stock has no expiration date.
  • [F4]Represents shares of Common Stock forfeited to the Issuer for no consideration in connection with the Issuer's initial business combination.

Documents

1 file

Issuer

CERO THERAPEUTICS HOLDINGS, INC.

CIK 0001870404

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001870407

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 7:38 PM ET
Size
16.4 KB